Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index |  Total Docs. (2008) |
Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | %Female (2008) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 323 | American Journal of Drug Delivery | journal | 0.375 Q3 | 23 | 0 | 49 | 0 | 63 | 43 | 1.64 | 0.00 | 0.00 |  |
| 322 | American Journal of PharmacoGenomics | journal | 0.682 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
| 321 | Asia Pacific Journal of Pharmacology | journal | 0.102 Q4 | 10 | 0 | 10 | 0 | 0 | 9 | 0.00 | 0.00 | 0.00 |  |
| 320 | Biogenic Amines | journal | 0.123 Q4 | 16 | 0 | 75 | 0 | 19 | 74 | 0.14 | 0.00 | 0.00 |  |
| 319 | Cardiovascular Drug Reviews | journal | 1.317 Q1 | 54 | 0 | 70 | 0 | 273 | 68 | 4.52 | 0.00 | 0.00 |  |
| 318 | Ciencia y Tecnologia Pharmaceutica | journal | 0.100 Q4 | 6 | 0 | 55 | 0 | 1 | 45 | 0.00 | 0.00 | 0.00 |  |
| 317 | CNS Drug Reviews | journal | 1.552 Q1 | 64 | 0 | 72 | 0 | 326 | 72 | 5.02 | 0.00 | 0.00 | |
| 316 | Current Drug Targets: Inflammation and Allergy | journal | 1.632 Q1 | 53 | 0 | 88 | 0 | 431 | 79 | 0.00 | 0.00 | 0.00 |  |
| 315 | Current Issues in Pharmacy and Medical Sciences | journal | 0.107 Q4 | 13 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |  |
| 314 | Current Pharmacogenomics | journal | 0.200 Q3 | 12 | 0 | 84 | 0 | 41 | 84 | 0.38 | 0.00 | 0.00 | |
| 313 | Drugs under Experimental and Clinical Research | journal | 0.335 Q3 | 41 | 0 | 36 | 0 | 64 | 36 | 0.00 | 0.00 | 0.00 |  |
| 312 | Hindustan Antibiotics Bulletin | journal | 0.101 Q4 | 10 | 0 | 16 | 0 | 0 | 16 | 0.00 | 0.00 | 0.00 |  |
| 311 | Japanese Journal of Psychopharmacology | journal | 0.111 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |  |
| 310 | Journal of Phytomedicine and Therapeutics | journal | 0.102 Q4 | 6 | 0 | 24 | 0 | 1 | 24 | 0.06 | 0.00 | 0.00 |  |
| 309 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.131 Q4 | 40 | 0 | 32 | 0 | 7 | 32 | 0.39 | 0.00 | 0.00 | |
| 308 | Supportive Cancer Therapy | journal | 0.153 Q4 | 15 | 0 | 66 | 0 | 20 | 55 | 0.30 | 0.00 | 0.00 | |
| 307 | Taiwan Pharmaceutical Journal | journal | 0.101 Q4 | 5 | 0 | 25 | 0 | 0 | 25 | 0.00 | 0.00 | 0.00 |  |
| 306 | Toxicological Reviews | journal | 0.686 Q2 | 49 | 0 | 49 | 0 | 165 | 42 | 3.35 | 0.00 | 0.00 | |
| 305 | Journal of Herbal Pharmacotherapy | journal | 0.233 Q3 | 33 | 1 | 88 | 0 | 62 | 83 | 0.49 | 0.00 | 0.00 | |
| 304 | Journal of Clinical Research | journal | 0.359 Q3 | 12 | 3 | 7 | 113 | 13 | 7 | 0.33 | 37.67 | 63.64 | |
| 303 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.139 Q4 | 29 | 3 | 29 | 313 | 5 | 24 | 0.00 | 104.33 | 0.00 | |
| 302 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.780 Q1 | 70 | 5 | 25 | 733 | 150 | 25 | 6.47 | 146.60 | 36.36 |  |
| 301 | Adverse Drug Reaction Bulletin | journal | 0.113 Q4 | 8 | 6 | 18 | 177 | 3 | 18 | 0.17 | 29.50 | 33.33 | |
| 300 | National Toxicology Program technical report series | journal | 0.221 | 22 | 7 | 20 | 0 | 15 | 20 | 0.82 | 0.00 | 0.00 | |
| 299 | Perspectives in Medicinal Chemistry | journal | 17 | 7 | 0 | 666 | 0 | 0 | 0.00 | 95.14 | 16.67 |  | |
| 298 | Psychopharmakotherapie, Supplement | journal | 0.101 Q4 | 2 | 7 | 40 | 121 | 0 | 29 | 0.00 | 17.29 | 20.00 | |
| 297 | Advances in Molecular Toxicology | book series | 0.146 Q4 | 18 | 8 | 6 | 1048 | 1 | 5 | 0.17 | 131.00 | 41.18 | |
| 296 | Journal of Immune Based Therapies and Vaccines | journal | 0.406 Q3 | 21 | 8 | 25 | 340 | 31 | 25 | 1.06 | 42.50 | 31.11 | |
| 295 | Progress in Medicinal Chemistry | journal | 1.350 Q1 | 38 | 8 | 21 | 1130 | 66 | 18 | 2.08 | 141.25 | 0.00 | |
| 294 | Paediatric and Perinatal Drug Therapy | journal | 0.233 Q3 | 20 | 9 | 64 | 192 | 45 | 54 | 0.74 | 21.33 | 48.48 | |
| 293 | Pharmaceutische Weekblad Wetenschappelijk Platform | journal | 2 | 10 | 0 | 131 | 0 | 0 | 0.00 | 13.10 | 23.68 | | |
| 292 | International Journal of Neuroprotection and Neuroregeneration | journal | 0.145 Q4 | 5 | 11 | 44 | 581 | 12 | 39 | 0.27 | 52.82 | 24.00 | |
| 291 | BMC Clinical Pharmacology | journal | 0.571 Q2 | 43 | 12 | 28 | 350 | 87 | 28 | 2.27 | 29.17 | 44.90 | |
| 290 | Journal of Applied Therapeutic Research | journal | 0.119 Q4 | 8 | 12 | 19 | 205 | 6 | 19 | 0.33 | 17.08 | 28.30 | |
| 289 | Journal of International Peacekeeping | journal | 0.101 Q4 | 14 | 12 | 53 | 155 | 1 | 51 | 0.03 | 12.92 | 23.08 | |
| 288 | Autonomic and Autacoid Pharmacology | journal | 0.382 Q3 | 24 | 13 | 112 | 439 | 107 | 111 | 0.97 | 33.77 | 35.85 | |
| 287 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.195 Q1 | 82 | 13 | 37 | 2583 | 142 | 37 | 3.65 | 198.69 | 34.00 | |
| 286 | Annual Report of Shionogi Research Laboratory | journal | 0.104 Q4 | 2 | 14 | 5 | 0 | 0 | 5 | 0.00 | 0.00 | 16.67 | |
| 285 | Phytomedica | journal | 0.100 Q4 | 4 | 14 | 49 | 108 | 0 | 49 | 0.00 | 7.71 | 15.00 | |
| 284 | Clinical Research and Regulatory Affairs | journal | 0.132 Q4 | 18 | 16 | 31 | 522 | 8 | 31 | 0.24 | 32.63 | 26.09 | |
| 283 | Current Topics in Pharmacology | journal | 0.101 Q4 | 8 | 16 | 36 | 1219 | 1 | 36 | 0.03 | 76.19 | 35.14 | |
| 282 | Drug Resistance Updates | journal | 2.826 Q1 | 132 | 16 | 65 | 2260 | 527 | 63 | 9.17 | 141.25 | 38.00 | |
| 281 | Pharmacopeial Forum (discontinued) | journal | 0.531 Q3 | 20 | 16 | 31 | 169 | 23 | 31 | 0.89 | 10.56 | 21.74 | |
| 280 | Pharmakeftiki | journal | 6 | 16 | 0 | 515 | 0 | 0 | 0.00 | 32.19 | 54.55 |  | |
| 279 | Advances in Pharmacology | journal | 1.129 Q1 | 86 | 17 | 76 | 2561 | 187 | 70 | 2.88 | 150.65 | 30.23 | |
| 278 | Antiviral Chemistry and Chemotherapy | journal | 0.671 Q2 | 59 | 17 | 98 | 901 | 202 | 97 | 1.97 | 53.00 | 22.86 | |
| 277 | Chinese Medicine | journal | 0.366 Q3 | 56 | 17 | 17 | 777 | 43 | 16 | 2.53 | 45.71 | 36.25 | |
| 276 | European Journal of Oncology Pharmacy | journal | 6 | 17 | 0 | 77 | 0 | 0 | 0.00 | 4.53 | 29.17 |  | |
| 275 | Archivos Venezolanos de Farmacologia y Terapeutica (discontinued) | journal | 0.101 Q4 | 11 | 18 | 26 | 665 | 0 | 24 | 0.00 | 36.94 | 40.00 |  |
| 274 | Core Evidence (discontinued) | journal | 0.120 Q4 | 29 | 18 | 30 | 1192 | 2 | 29 | 0.00 | 66.22 | 19.44 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data